Israel - Ibrani - Ministry of Health

pfizer pharmaceuticals israel ltd - ampicillin as sodium 500 mg; sulbactam as sodium 250 mg - powder for solution for injection - ampicillin and enzyme inhibitor - sulbactam sodium/ampicillin sodium im/iv is indicated for the treatment of infections due to susceptible beta-lactamase producing strains of microorganisms in the following conditions: 1) skin and skin structure infections. 2) intra-abdominal infections. 3) gynecological infections.

Israel - Ibrani - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ampicillin as sodium; sulbactam as sodium - אבקה להכנת תמיסה לזריקה - ampicillin as sodium 1000 mg; sulbactam as sodium 500 mg - ampicillin and enzyme inhibitor - ampicillin and enzyme inhibitor - sulbactam sodium/ampicillin sodium im/iv is indicated for the treatment of infections due to susceptible beta-lactamase producing strains of microorganisms in the following conditions: 1) skin and skin structure infections. 2) intra-abdominal infections. 3) gynecological infections.

Israel - Ibrani - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ampicillin as sodium; sulbactam as sodium - אבקה להכנת תמיסה לזריקה - ampicillin as sodium 2000 mg; sulbactam as sodium 1000 mg - ampicillin and enzyme inhibitor - ampicillin and enzyme inhibitor - sulbactam sodium/ampicillin sodium im/iv is indicated for the treatment of infections due to susceptible beta-lactamase producing strains of microorganisms in the following conditions: 1) skin and skin structure infections. 2) intra-abdominal infections. 3) gynecological infections.

Israel - Ibrani - Ministry of Health

comex ltd - amoxicillin trihydrate 200 mg; clavulanic acid as potassium 50 mg - tablets - amoxicillin and enzyme inhibitor - for dogs : treatment of the following infections caused by beta lactamase producing strains of bacteria sensitive to amoxicillin in combination with clavulanic acid : skin infections ( including superficial and deep pyodermas ) caused by susceptible staphylococci. urinary tract infections caused by susceptible staphylococci or escherichia coli. respiratory infections caused by susceptible staphylococci. enteritis caused by susceptible escherichia coli.

Israel - Ibrani - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - azithromycin as dihydrate - אבקה להכנת תמיסה לאינפוזיה - azithromycin as dihydrate 500 mg/vial - azithromycin - azithromycin - treatment of infections caused by susceptible strains of the designated microorganisms in the following conditions: community-acquired pneumonia and pelvic inflammatory disease.

Israel - Ibrani - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - azithromycin as dihydrate - אבקה להכנת תמיסה לאינפוזיה - azithromycin as dihydrate 500 mg/vial - azithromycin - azithromycin - treatment of infections caused by susceptible strains of the designated microorganisms in the following conditions: community-acquired pneumonia and pelvic inflammatory disease.

Israel - Ibrani - Ministry of Health

pfizer pharmaceuticals israel ltd - azithromycin - אבקה להכנת תרחיף - azithromycin 2.096 g - azithromycin - azithromycin - zmax is indicated for the treatment of patients 18 years of age and above with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. adults: acute bacterial sinusitis due to haemophilus influenzae moraxella catarrhalis or streptococcus pneumoniae. community-acquired pneumonia due to chlamydophila pneumoniae, haemophilus influenzae mycoplasma pneumoniae or streptococcus pneumoniae in patients appropriate for oral therapy.

Israel - Ibrani - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - clindamycin hydrochloride - קפסולות - clindamycin hydrochloride 150 mg - clindamycin - clindamycin - treatment of infections caused by susceptible strains of anaerobic microorganisms.

Israel - Ibrani - Ministry of Health

rafa laboratories ltd - clindamycin as phosphate - תמיסה להזרקה - clindamycin as phosphate 150 mg/ml - clindamycin - clindamycin - the treatment of infections caused by susceptible strains of microorganisms.

Israel - Ibrani - Ministry of Health

novartis israel ltd - moxifloxacin as hydrochloride - תמיסה לעין - moxifloxacin as hydrochloride 0.5 % - moxifloxacin - moxifloxacin - for the treatment of bacterial conjunctivitis caused by susceptible strains or organisms.